אוליקלינומל N4-550E ישראל - עברית - Ministry of Health

אוליקלינומל n4-550e

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined soya-bean oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - תחליב לאינפוזיה - glycine 5.67 g / 1000 ml; l- alanine 11.39 g / 1000 ml; l-histidine 2.64 g / 1000 ml; l-arginine 6.33 g / 1000 ml; l- methionine 2.20 g / 1000 ml; l- lysine as hydrochloride 3.19 g / 1000 ml; l- isoleucine 3.30 g / 1000 ml; l- threonine 2.31 g / 1000 ml; l- tryptophan 0.99 g / 1000 ml; l- proline 3.74 g / 1000 ml; l- phenylalanine 3.08 g / 1000 ml; l- valine 3.19 g / 1000 ml; l- tyrosine 0.22 g / 1000 ml; l- leucine 4.02 g / 1000 ml; l- serine 2.75 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 2.45 g / 1000 ml; refined soya-bean oil 100 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 200 g / 1000 ml; potassium chloride 2.98 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

אוליקלינומל N7-1000 ישראל - עברית - Ministry of Health

אוליקלינומל n7-1000

teva medical marketing ltd. - glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; refined soya-bean oil - תחליב לאינפוזיה - refined soya-bean oil 200 g / 1000 ml; glucose as monohydrate 400 g / 1000 ml; l- valine 5.80 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 1.80 g / 1000 ml; l- threonine 4.20 g / 1000 ml; l- serine 5.00 g / 1000 ml; l- proline 6.80 g / 1000 ml; l- phenylalanine 5.60 g / 1000 ml; l- methionine 4.00 g / 1000 ml; l- lysine as hydrochloride 5.80 g / 1000 ml; l- leucine 7.30 g / 1000 ml; l- isoleucine 6.00 g / 1000 ml; l-histidine 4.80 g / 1000 ml; glycine 10.30 g / 1000 ml; l-arginine 11.50 g / 1000 ml; l- alanine 20.70 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

אוליקלינומל N5-800E ישראל - עברית - Ministry of Health

אוליקלינומל n5-800e

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined soya-bean oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - תחליב לאינפוזיה - refined soya-bean oil 200.00 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 250.00 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml; potassium chloride 4.47 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 6.12 g / 1000 ml; l- valine 4.06 g / 1000 ml; l- tyrosine 0.28 g / 1000 ml; l- tryptophan 1.26 g / 1000 ml; l- threonine 2.94 g / 1000 ml; l- serine 3.50 g / 1000 ml; l- proline 4.76 g / 1000 ml; l- phenylalanine 3.92 g / 1000 ml; l- methionine 2.80 g / 1000 ml; l- lysine as hydrochloride 4.06 g / 1000 ml; l- leucine 5.11 g / 1000 ml; l- isoleucine 4.20 g / 1000 ml; l-histidine 3.36 g / 1000 ml; glycine 7.21 g / 1000 ml; l-arginine 8.05 g / 1000 ml; l- alanine 14.49 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

אוליקלינומל N7-1000E ישראל - עברית - Ministry of Health

אוליקלינומל n7-1000e

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride; potassium chloride; refined soya-bean oil; sodium acetate dihydrate; sodium glycerophosphate - תחליב לאינפוזיה - refined soya-bean oil 200 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 4000.00 g / 1000 ml; magnesium chloride 1.12 g / 1000 ml; potassium chloride 4.47 g / 1000 ml; sodium glycerophosphate 5.36 g / 1000 ml; sodium acetate dihydrate 6.12 g / 1000 ml; l- valine 5.80 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 1.80 g / 1000 ml; l- threonine 4.20 g / 1000 ml; l- serine 5.00 g / 1000 ml; l- proline 6.80 g / 1000 ml; l- phenylalanine 5.60 g / 1000 ml; l- methionine 4.00 g / 1000 ml; l- lysine as hydrochloride 5.80 g / 1000 ml; l- leucine 7.30 g / 1000 ml; l- isoleucine 6.00 g / 1000 ml; l-histidine 4.80 g / 1000 ml; glycine 10.30 g / 1000 ml; l-arginine 11.50 g / 1000 ml; l- alanine 20.70 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

גלוקוז % 5 לעירוי לתוך הוריד BP ישראל - עברית - Ministry of Health

גלוקוז % 5 לעירוי לתוך הוריד bp

teva medical marketing ltd. - glucose monohydrate - תמיסה לאינפוזיה - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.

גלוקוז % 5 לעירוי לתוך הוריד BP ישראל - עברית - Ministry of Health

גלוקוז % 5 לעירוי לתוך הוריד bp

teva medical marketing ltd. - glucose monohydrate - תמיסה לאינפוזיה - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.

גלוקוז % 5 לעירוי לתוך הוריד BP ישראל - עברית - Ministry of Health

גלוקוז % 5 לעירוי לתוך הוריד bp

teva medical marketing ltd. - glucose monohydrate - תמיסה לאינפוזיה - glucose monohydrate 5.5 %w/v - glucose - glucose - for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.

תמיסת דקסטרוז % 10 להזרקה ישראל - עברית - Ministry of Health

תמיסת דקסטרוז % 10 להזרקה

teva medical marketing ltd. - glucose as monohydrate - תמיסה להזרקה - glucose as monohydrate 10 % - glucose - glucose - as intravenous injection: dextrose 10 % injection is indicated as a source of water and calories. as parenteral nutrient: dextrose 10 % injection is indicated as a caloric component in parenteral nutrition regimen. it is used with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1) the alimentary tract cannot should not be used. 2) gastrointestinal absorption of protein is impaired, or 3) metabolic requirements for protein are substantially increased, as extensive burns.

דקסטרוז % 5 ישראל - עברית - Ministry of Health

דקסטרוז % 5

lapidot medical import and marketing ltd - glucose as monohydrate - תמיסה לאינפוזיה - glucose as monohydrate 5 g / 100 ml - glucose - glucose - vehicle solution for supplementary medication. energy supply, hypertonic dehydration.

דקסטרוז תמיסה להזרקה % 20 ישראל - עברית - Ministry of Health

דקסטרוז תמיסה להזרקה % 20

teva medical marketing ltd. - glucose as monohydrate - תמיסה לאינפוזיה - glucose as monohydrate 20 g / 100 ml - glucose - glucose - dextrose injection is indicated as a caloric compnent in parenteral nutrition regimen. it is used with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1) the alimentary tract cannot/should not be used 2) gastrointestinal absorption of protein is impaired or 3) metabolic requirement sfor protein are substantially increases as extensive burns.